ETS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.035800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.457600E-01
Normal-vs-Stage2
4.123400E-01
Normal-vs-Stage3
3.662000E-01
Normal-vs-Stage4
3.975000E-01
Stage1-vs-Stage2
3.088400E-01
Stage1-vs-Stage3
6.235400E-01
Stage1-vs-Stage4
3.675400E-01
Stage2-vs-Stage3
5.746400E-01
Stage2-vs-Stage4
8.346800E-01
Stage3-vs-Stage4
6.228400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.040800E-01
Normal-vs-AfricanAmerican
4.525400E-01
Normal-vs-Asian
3.238200E-01
Caucasian-vs-AfricanAmerican
5.831400E-01
Caucasian-vs-Asian
2.497200E-03
AfricanAmerican-vs-Asian
1.566620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.827400E-01
Normal-vs-Female
4.316800E-01
Male-vs-Female
5.583800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.668400E-01
Normal-vs-Age(41-60Yrs)
4.450800E-01
Normal-vs-Age(61-80Yrs)
3.883600E-01
Normal-vs-Age(81-100Yrs)
3.773600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.828000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.101400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.712200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.390000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.592420E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.059000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.835800E-01
Normal-vs-Daily Drinker
3.637800E-01
Normal-vs-Weekly Drinker
3.644000E-01
Normal-vs-Occasional Drinker
3.939400E-01
Normal-vs-Social Drinker
4.135400E-01
Non Drinker-vs-Daily Drinker
6.198000E-01
Non Drinker-vs-Weekly Drinker
6.076800E-01
Non Drinker-vs-Occasional Drinker
8.135800E-01
Non Drinker-vs-Social Drinker
5.782600E-01
Daily Drinker-vs-Weekly Drinker
9.816200E-01
Daily Drinker-vs-Occasional Drinker
4.217200E-01
Daily Drinker-vs-Social Drinker
2.823200E-01
Weekly Drinker-vs-Occasional Drinker
4.404400E-01
Weekly Drinker-vs-Social Drinker
3.072200E-01
Occasional Drinker-vs-Social Drinker
7.132200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.963200E-01
Normal-vs-Grade 2
3.973000E-01
Normal-vs-Grade 3
3.315800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.152800E-01
Grade 1-vs-Grade 3
9.832400E-01
Grade 1-vs-Grade 4
6.963200E-01
Grade 2-vs-Grade 3
4.298600E-01
Grade 2-vs-Grade 4
3.973000E-01
Grade 3-vs-Grade 4
3.315800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.206400E-01
Normal-vs-NonDiabetic
3.842000E-01
Diabetic-vs-NonDiabetic
2.892400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.621600E-01
Normal-vs-NoPancreatitis
3.987800E-01
Pancreatitis-vs-NoPancreatitis
1.787230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.870000E-01
Normal-vs-N1
4.147000E-01
N0-vs-N1
3.724000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.044200E-01
Normal-vs-TP53-NonMutant
3.409600E-01
TP53-Mutant-vs-TP53-NonMutant
2.535000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
